Patent details

Basic Information

Publication number:

EP2567690

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP121880470

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of amisulpride for treating chemotherapy-induced nausea and vomiting

French Title of Invention:

Utilisation de l'amisulpride pour le traitement des nausées et vomissements induits par la chimiothérapie

German Title of Invention:

Verwendung von Amisulprid zur Behandlung von Chemotherapie-induzierten Übelkeit und Erbrechen

SPC Number:

Dates

Filing date:

10/03/2011

Grant date:

16/07/2014

EP Publication Date:

16/07/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/03/2013

EP B1 Publication Date:

16/07/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/03/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/03/2011

 

 

Name:

Acacia Pharma Limited

Address:

Harston Mill, Harston Cambridgeshire CB22 7GG, United Kingdom (GB)

Inventor

1

Name:

Gristwood Robert William

Address:

United Kingdom (GB)

2

Name:

Gilbert Julian Clive

Address:

United Kingdom (GB)

3

Name:

Cooper Nicola

Address:

United Kingdom (GB)

4

Name:

Fox Gabriel

Address:

United Kingdom (GB)

Priority

Priority Number:

201004020

Priority Date:

11/03/2010

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/00;

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/03/2025

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages